A

Acotec Scientific Holdings
6669

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$2.57B
EV
HK$1.87B
Shares Outstanding
313.39M
Beta
0.27

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$11.94
P/E 2025E
21.42x
P/Revenue 2025E
3.39x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Acotec Scientific Holdings Limited

gainify

A

Acotec Scientific Holdings Limited

6669

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China, Europe, and internationally. The company’s products include AcoArt Orchid & Dhalia, a paclitaxel DCB used ...

Sector

Healthcare

Industry

Medical - Devices

CEO

Li, Jing

Employees

650

IPO Date

2021-08-24

Headquarters

Building No. 1, 4-5th Floor, 16 North Hongda Road, Beijing Economic-Technological Dev. Area, Beijing China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved